FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100579986> ?p ?o ?g. }

• W2100579986 endingPage "26" @default.
• W2100579986 startingPage "22" @default.
• W2100579986 abstract "Practice NursingVol. 26, No. 1 Infectious DiseaseScreening for and diagnosing hepatitis CRay PollRay PollSearch for more papers by this authorRay PollPublished Online:29 Dec 2014https://doi.org/10.12968/pnur.2015.26.1.22AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View articleAbstractRay Poll highlights the important role practice nurses play in identifying cases of hepatitis C References Booth JCL, O'Grady J, Neuberger J (2001) Clinical guidelines on the management of hepatitis C. Gut 49(Suppl 1): I1–21 doi: https://doi.org/10.1136/gut.49.suppl_1.I1 Crossref, Google ScholarBritish Association of Sexual Health and HIV (2008) United Kingdom National Guideline on the Management of the Viral Hepatitides A, B and C. www.bashh.org/documents/1927.pdf (accessed 3 October 2014) Google ScholarBritish HIV Association (2013) British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013. HIV Medicine 14(Suppl 4): 1–71. www.bhiva.org/documents/Guidelines/Hepatitis/2013/HepatitisGuidelines2013.pdf (accessed 3 October 2014) Google ScholarDepartment of Health (2002) Hepatitis C Strategy for England. www.nhs.uk/hepatitisc/SiteCollectionDocuments/pdf/hepatitis-c-strategy-for-england.pdf (accessed 3 October 2014) Google ScholarDepartment of Health (2004) Hepatitis C Action Plan for England. www.nhs.uk/hepatitisc/SiteCollectionDocuments/pdf/hepatitis-c-action-plan-for-england.pdf (accessed 3 October 2014) Google ScholarEuropean Association for the Study of the Liver (2014) EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol 60(2): 392–420. doi: https://doi.org/10.1016/j.jhep.2013.11.003 Crossref, Google ScholarHealth Protection Agency (2011) Hepatitis C in the UK: 2011 report. www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1309969906418 (accessed 3 October 2014) Google ScholarHepatitis C Trust (2013) The Uncomfortable Truth – Hepatitis C in England: The State of the Nation. www.hepctrust.org.uk/Resources/HepC%20New/The%20Trust/The%20Uncomfortable%20Truth.pdf (accessed 3 October 2014) Google ScholarHirsch KR, Wright TL (2000) ‘Silent killer’ or benign disease? The dilemma of hepatitis C virus outcomes. Hepatology 31(2): 536–7. doi: https://doi.org/10.1002/hep.510310241 Crossref, Google ScholarLawitz E, Mangia A, Wyles D et al. (2013) Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 368(20): 1878–87. doi: https://doi.org/10.1056/NEJMoa1214853 Crossref, Google ScholarNational Institute for Health and Care Excellence (2006) Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. NICE technology appraisal guidance 106. www.nice.org.uk/guidance/ta106/resources/guidance-peginterferon-alfa-and-ribavirin-for-the-treatment-of-mild-chronic-hepatitis-c-pdf (accessed 3 October 2014) Google ScholarNational Institute for Health and Care Excellence (2012a) Telaprevir for the treatment of genotype 1 chronic hepatitis C. NICE technology appraisal 252. www.nice.org.uk/guidance/ta252/resources/guidance-telaprevir-for-the-treatment-of-genotype-1-chronic-hepatitis-c-pdf (accessed 3 October 2014) Google ScholarNational Institute for Health and Care Excellence (2012b) Boceprevir for the treatment of genotype 1 chronic hepatitis C. NICE technology appraisal 253. www.nice.org.uk/guidance/ta253/resources/guidance-boceprevir-for-the-treatment-of-genotype1-chronic-hepatitisc-pdf (accessed 3 October 2014) Google ScholarNational Institute for Health and Care Excellence (2012c) Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection. NICE public heath guidance 43. http://www.nice.org.uk/guidance/ph43/resources/guidance-hepatitis-b-and-c-ways-to-promote-and-offer-testing-to-people-at-increased-risk-of-infection-pdf (accessed 3 October 2014) Google ScholarPublic Health England (2013a) Hepatitis C in the UK: 2013 report. www.hepctrust.org.uk/Resources/HepC%20New/Hep%20C%20Resources/Reports/Hepatitis%20C%20in%20the%20UK%20HPA%202013%20report.pdf (accessed 3 October 2014) Google ScholarPublic Health England (2013b) Shooting up: Infections among people who inject drugs in the UK 2012. www.gov.uk/government/uploads/system/uploads/attachment_data/file/329515/Shooting_Up_update_2013.pdf (accessed 3 October 2014) Google ScholarRamachandran P, Fraser A, Agarwal K et al. (2012) UK consensus guidelines for the use of protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Ailment Pharmacol Ther 35(6): 647–62. doi: https://doi.org/10.1111/j.1365-2036.2012.04992.x Crossref, Google ScholarSalisbury D, Ramsay M, eds (2013) Immunisation against Infectious Disease [‘the Green Book’]. www.dh.gov.uk/greenbook (accessed 14 January 2014) Google ScholarSoldan K, Barbara JA, Ramsay ME et al. (2003) Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 84(4): 274–86 Crossref, Google ScholarTurner J, Bansi L, Gilson R et al. (2010) The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK—trends in HCV testing and the impact of HCV on HIV treatment outcomes. J Viral Hepat 17(8): 569–77. doi: https://doi.org/10.1111/j.1365-2893.2009.01215.x Crossref, Google ScholarUddin G, Shoeb D, Solaiman S et al. (2010) Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot be necessarily predicted from the prevalence in the country of origin. J Viral Hepat 17(5): 327–35. doi: https://doi.org/10.1111/j.1365-2893.2009.01240.x Crossref, Google ScholarWorld Health Organization (2014) Guidelines for the screening, care and treatment of persons with hepatitis C infection. http://apps.who.int/iris/bitstream/10665/111747/1/9789241548755_eng.pdf?ua=1&ua=1 (accessed 3 October 2014) Google ScholarZeuzem S, Berg T, Gane E et al. (2014) Simeprevir increases rate of sustained virological response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial. Gastroenterology 146(2): 430–441. doi: https://doi.org/10.1053/j.gastro.2013.10.058 Crossref, Google Scholar FiguresReferencesRelatedDetailsCited byJournal Scan17 April 2015 | Gastrointestinal Nursing, Vol. 13, No. 3 2 January 2015Volume 26Issue 1ISSN (print): 0964-9271ISSN (online): 2052-2940 Metrics History Received 18 July 2014 Accepted 2 October 2014 Published online 29 December 2014 Published in print 2 January 2015 Information© MA Healthcare LimitedKeywordshepatitis Cliver diseasedrug useglobaltestingPDF download" @default.
• W2100579986 created "2016-06-24" @default.
• W2100579986 creator A5002695911 @default.
• W2100579986 date "2015-01-02" @default.
• W2100579986 modified "2023-09-26" @default.
• W2100579986 title "Screening for and diagnosing hepatitis C" @default.
• W2100579986 cites W1837801955 @default.
• W2100579986 cites W1984974276 @default.
• W2100579986 cites W2001343407 @default.
• W2100579986 cites W2052005188 @default.
• W2100579986 cites W2078251659 @default.
• W2100579986 cites W2114223742 @default.
• W2100579986 cites W2130783809 @default.
• W2100579986 cites W2169503918 @default.
• W2100579986 cites W4210961054 @default.
• W2100579986 doi "https://doi.org/10.12968/pnur.2015.26.1.22" @default.
• W2100579986 hasPublicationYear "2015" @default.
• W2100579986 type Work @default.
• W2100579986 sameAs 2100579986 @default.
• W2100579986 citedByCount "1" @default.
• W2100579986 countsByYear W21005799862015 @default.
• W2100579986 crossrefType "journal-article" @default.
• W2100579986 hasAuthorship W2100579986A5002695911 @default.
• W2100579986 hasConcept C142724271 @default.
• W2100579986 hasConcept C159047783 @default.
• W2100579986 hasConcept C162324750 @default.
• W2100579986 hasConcept C187736073 @default.
• W2100579986 hasConcept C2522874641 @default.
• W2100579986 hasConcept C2775876817 @default.
• W2100579986 hasConcept C2776029263 @default.
• W2100579986 hasConcept C2776408679 @default.
• W2100579986 hasConcept C2776455275 @default.
• W2100579986 hasConcept C2777072776 @default.
• W2100579986 hasConcept C2780182762 @default.
• W2100579986 hasConcept C2780210234 @default.
• W2100579986 hasConcept C3013748606 @default.
• W2100579986 hasConcept C512399662 @default.
• W2100579986 hasConcept C71924100 @default.
• W2100579986 hasConceptScore W2100579986C142724271 @default.
• W2100579986 hasConceptScore W2100579986C159047783 @default.
• W2100579986 hasConceptScore W2100579986C162324750 @default.
• W2100579986 hasConceptScore W2100579986C187736073 @default.
• W2100579986 hasConceptScore W2100579986C2522874641 @default.
• W2100579986 hasConceptScore W2100579986C2775876817 @default.
• W2100579986 hasConceptScore W2100579986C2776029263 @default.
• W2100579986 hasConceptScore W2100579986C2776408679 @default.
• W2100579986 hasConceptScore W2100579986C2776455275 @default.
• W2100579986 hasConceptScore W2100579986C2777072776 @default.
• W2100579986 hasConceptScore W2100579986C2780182762 @default.
• W2100579986 hasConceptScore W2100579986C2780210234 @default.
• W2100579986 hasConceptScore W2100579986C3013748606 @default.
• W2100579986 hasConceptScore W2100579986C512399662 @default.
• W2100579986 hasConceptScore W2100579986C71924100 @default.
• W2100579986 hasIssue "1" @default.
• W2100579986 hasLocation W21005799861 @default.
• W2100579986 hasOpenAccess W2100579986 @default.
• W2100579986 hasPrimaryLocation W21005799861 @default.
• W2100579986 hasRelatedWork W104411371 @default.
• W2100579986 hasRelatedWork W1987769824 @default.
• W2100579986 hasRelatedWork W1987880988 @default.
• W2100579986 hasRelatedWork W2030990176 @default.
• W2100579986 hasRelatedWork W2066817493 @default.
• W2100579986 hasRelatedWork W2162302565 @default.
• W2100579986 hasRelatedWork W2980472629 @default.
• W2100579986 hasRelatedWork W3135636381 @default.
• W2100579986 hasRelatedWork W4235931300 @default.
• W2100579986 hasRelatedWork W4237060995 @default.
• W2100579986 hasVolume "26" @default.
• W2100579986 isParatext "false" @default.
• W2100579986 isRetracted "false" @default.
• W2100579986 magId "2100579986" @default.
• W2100579986 workType "article" @default.